ZDHHC9 and neoplasm: These findings suggest that aberrant ZDHHC9 expression may promote carcinogenic behaviors in BC by influencing cell cycle regulation, DNA repair mechanisms, and tumor immunity, suggesting its value as a therapeutic target for BC treatment.